Molecular optical imaging: Applications leading to the development of present day therapeutics

SummaryA number of advances in the molecular imaging field have led to the sensing of specific molecular targets and pathways in living animals. In the optical imaging field, these include the designing of biocompatible near-infrared fluorochromes, development of targeted and activatable “smart” imaging probes, and engineering of activatable fluorescent and bioluminescent proteins. The current advances in molecular optical imaging will help in early disease diagnoses, functioning of a number of pathways and finally help speed drug discovery. In this review, we will describe the near infrared fluorescent and bioluminescence imaging modalities and how these techniques have been employed in current research. Furthermore, we will also shed some light on the use of these imaging modalities in neurotherapeutics, for example imaging different parameters of vector-mediated gene expression in glioma tumors and stem cell trackingin vivo.

[1]  David J. Brooks,et al.  Positron emission tomography and single-photon emission computed tomography in central nervous system drug development , 2005, NeuroRX.

[2]  Brian D. Ross,et al.  Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making , 2005, NeuroRX.

[3]  Gary H. Glover,et al.  Foundations of advanced magnetic resonance imaging , 2005, NeuroRX.

[4]  Ralph Weissleder,et al.  Glioma therapy and real‐time imaging of neural precursor cell migration and tumor regression , 2005, Annals of neurology.

[5]  M. Devous Single-photon emission computed tomography in neurotherapeutics , 2005 .

[6]  A. Söling,et al.  A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma , 2004, Genetic vaccines and therapy.

[7]  R. Weissleder,et al.  Molecular imaging of gene therapy for cancer , 2004, Gene Therapy.

[8]  R. Weissleder,et al.  Molecular Imaging of Factor XIIIa Activity in Thrombosis Using a Novel, Near-Infrared Fluorescent Contrast Agent That Covalently Links to Thrombi , 2004, Circulation.

[9]  R. Weissleder,et al.  Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas , 2004, Cancer Research.

[10]  R. Weissleder,et al.  Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy. , 2004, Cancer research.

[11]  Ralph Weissleder,et al.  A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. , 2004, Neoplasia.

[12]  R. Weissleder,et al.  In Vivo Imaging of HIV Protease Activity in Amplicon Vector-transduced Gliomas , 2004, Cancer Research.

[13]  Ralph Weissleder,et al.  Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo , 2003, Oncogene.

[14]  C. Gondi,et al.  Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis , 2003, Oncogene.

[15]  Ralph Weissleder,et al.  In vivo tracking of neural progenitor cell migration to glioblastomas. , 2003, Human gene therapy.

[16]  Vasilis Ntziachristos,et al.  Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. , 2003, Neoplasia.

[17]  Thomas L. Chenevert,et al.  Noninvasive real-time imaging of apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Melitta Schachner,et al.  Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons , 2002, Nature Biotechnology.

[19]  C. Contag,et al.  It's not just about anatomy: In vivo bioluminescence imaging as an eyepiece into biology , 2002, Journal of magnetic resonance imaging : JMRI.

[20]  John Calvin Reed,et al.  Apoptosis-based therapies , 2002, Nature Reviews Drug Discovery.

[21]  Thomas L. Chenevert,et al.  Molecular Imaging of Gene Expression and Efficacy following Adenoviral-Mediated Brain Tumor Gene Therapy , 2002 .

[22]  R Weissleder,et al.  Molecular imaging. , 2009, Radiology.

[23]  S. Gambhir,et al.  Optical imaging of Renilla luciferase reporter gene expression in living mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S S Gambhir,et al.  Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  B. Rice,et al.  In vivo imaging of light-emitting probes. , 2001, Journal of biomedical optics.

[26]  E. Galun,et al.  Imaging transgene expression in live animals. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy , 2001, Nature Medicine.

[28]  Ralph Weissleder,et al.  In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.

[29]  P. Williamson,et al.  Phosphatidylserine, a death knell , 2001, Cell Death and Differentiation.

[30]  W. Semmler,et al.  Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands , 2001, Nature Biotechnology.

[31]  P. Black,et al.  Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R Weissleder,et al.  In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.

[33]  A. Boveris,et al.  Nitric oxide production and mitochondrial dysfunction during rat thymocyte apoptosis. , 2000, Archives of biochemistry and biophysics.

[34]  T. Billiar,et al.  Cellular Non-heme Iron Content Is a Determinant of Nitric Oxide-mediated Apoptosis, Necrosis, and Caspase Inhibition* , 2000, The Journal of Biological Chemistry.

[35]  A. Jacobs,et al.  Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  C. Contag,et al.  Use of reporter genes for optical measurements of neoplastic disease in vivo. , 2000, Neoplasia.

[37]  C. Contag,et al.  Visualizing the kinetics of tumor-cell clearance in living animals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R Weissleder,et al.  Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. , 1999, Bioconjugate chemistry.

[39]  L. Matrisian,et al.  Measurement of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Blood and Tissues: Clinical and Experimental Applications , 1999, Annals of the New York Academy of Sciences.

[40]  V. Yee,et al.  Blood coagulation factor XIII: structure and function. , 1999, Thrombosis research.

[41]  Charles D. McDermott,et al.  Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials , 1999, Annals of the New York Academy of Sciences.

[42]  V. Dixit,et al.  Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.

[43]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[44]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[45]  R Weissleder,et al.  Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging. , 1998, AJR. American journal of roentgenology.

[46]  M A Moses,et al.  Increased incidence of matrix metalloproteinases in urine of cancer patients. , 1998, Cancer research.

[47]  C. Stiles Cancer of the central nervous system. Review of an AACR special conference in cancer research with the joint section on tumors of the AANS/CNS (San Diego, CA, June 7-11, 1997). , 1998, Biochimica et biophysica acta.

[48]  H K Rooprai,et al.  Proteases and their inhibitors in human brain tumours: a review. , 1997, Anticancer research.

[49]  William G. Stetler-Stevenson,et al.  Matrix Metalloproteinases , 1997, Drugs & aging.

[50]  R. Gentz,et al.  An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.

[51]  R. Kreis,et al.  Dipolar resonance frequency shifts in 1H MR spectra of skeletal muscle: Confirmation in rats at 4.7 T in Vivo and observation of changes postmortem , 1997, Magnetic resonance in medicine.

[52]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[53]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[54]  J. Mullins,et al.  Photonic detection of bacterial pathogens in living hosts , 1995, Molecular microbiology.

[55]  A. Hanby,et al.  Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.

[56]  M. Stearns,et al.  Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. , 1993, Cancer research.

[57]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[58]  C. Cepko,et al.  Multipotent neural cell lines can engraft and participate in development of mouse cerebellum , 1992, Cell.